AstraZeneca and Pieris Link on Respiratory Disease

17.05.2017 - AstraZeneca is to collaborate with US-based Pieris Pharmaceuticals to develop novel inhaled drugs for respiratory diseases. The deal will leverage Pieris’ Anticalin platform and...